Thursday, February 07, 2008 9:30:58 AM
Last update: 9:15 a.m. EST Feb. 7, 2008
TAMPA, Fla., Feb 07, 2008 (BUSINESS WIRE) -- Nanobac Pharmaceuticals Inc. ("Nanobac" or "the Company") is pleased to announce that it has engaged Guy Ricciardulli for services related to claims for damages, injury or loss out of patent infringement.
"We are pleased to have Guy and his exceptional team working with us on protecting our intellectual property estate," stated John Stanton, Nanobac's Chairman and CEO. "We are at a true turning point at Nanobac with our science, our products and our partnerships, and we need to protect our intellectual property estate."
Nanobac Pharmaceuticals Inc. is headquartered in Tampa, Florida. For more information, visit our website at: http://www.nanobac.com .
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM